 |
|
Thyroid cancer discovery points to new treatments, prevention
November 16, 2006The actions of a mutated protein in cells linked to thyroid cancer have been uncovered by researchers at Queen's University. The discovery paves the way for the future development of drugs to more effectively target, treat and possibly even prevent both inherited and non-inherited thyroid cancers.
"We now know why this gene causes these tumours and can start looking at how best to target the mutant proteins so that the cells expressing them can be killed or stopped from growing," says Lois Mulligan, professor of pathology and molecular medicine with the Division of Cancer Biology and Genetics of the Queen's Cancer Research Institute. She is senior author of a study to be published November 15 in the journal Cancer Research.
Taranjit S. Gujral, a Ph D student in Queen's Department of Pathology and Molecular Medicine and lead author on the paper, developed three-dimensional models of the mutated RET protein implicated in a condition causing cancerous thyroid tumours. The model allowed him to predict and compare the protein's molecular actions and to see that the protein was ten times more active than normal in cells associated with Multiple Endocrine Neoplasia 2B (MEN 2B) syndrome, an inherited cancer syndrome. Co-authors on the study include Vinay K. Singh and Zongchao Jia of Queen's Biochemistry Department.
"It's like stepping on the gas in a car and getting way more gas than you bargained for," says Mulligan. "The mutation may cause some new actions but it chiefly does some actions more efficiently than normal."
MEN 2B is a dominantly inherited condition - the most severe of its kind - and is characterized by the early onset of thyroid tumours, sometimes even affecting infants, and can also cause developmental abnormalities including elongated bones, gastric problems and bumpy lips.
MEN 2B is currently treated with surgery, and other treatments, such as radiation and chemotherapy are not very effective. The study provides valuable tools for specific targeting of the actions of the protein that may aid in the development of anticancer therapies.
The models created by Mr. Gujral, a Canadian Institutes of Health Research (CIHR) Trainee in Transdisciplinary Cancer Research and Protein Function Discovery, can be used further to help illuminate the actions of the protein with MEN 2B's other mutations. The research team credits the transdisciplinary approach and its benefits for providing fresh perspectives in generating the new understanding of RET's role in MEN 2B. Additional funding for the study came from the Canadian Cancer Society and the CIHR.
Queen's University
"It's like stepping on the gas in a car and getting way more gas than you bargained for," says Mulligan. "The mutation may cause some new actions but it chiefly does some actions more efficiently than normal."
MEN 2B is a dominantly inherited condition - the most severe of its kind - and is characterized by the early onset of thyroid tumours, sometimes even affecting infants, and can also cause developmental abnormalities including elongated bones, gastric problems and bumpy lips.
MEN 2B is currently treated with surgery, and other treatments, such as radiation and chemotherapy are not very effective. The study provides valuable tools for specific targeting of the actions of the protein that may aid in the development of anticancer therapies.
The models created by Mr. Gujral, a Canadian Institutes of Health Research (CIHR) Trainee in Transdisciplinary Cancer Research and Protein Function Discovery, can be used further to help illuminate the actions of the protein with MEN 2B's other mutations. The research team credits the transdisciplinary approach and its benefits for providing fresh perspectives in generating the new understanding of RET's role in MEN 2B. Additional funding for the study came from the Canadian Cancer Society and the CIHR.
Queen's University
Thyroid Cancer News and Current Thyroid Cancer Events RSSResearchers discover atomic bomb effect results in adult-onset thyroid cancer
Radiation from the atomic bomb blasts in Hiroshima and Nagasaki, Japan, in 1945, likely rearranged chromosomes in some survivors who later developed papillary thyroid cancer as adults, according to Japanese researchers.
Scans spot hidden tumors in rare cancer syndrome
Researchers at Dana-Farber Cancer Institute report that full-body PET/CT scanning detected unsuspected, treatable tumors in 3 of 15 patients with Li-Fraumeni syndrome (LFS), a rare genetic cancer syndrome for which no screening tests have been recommended.
Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl
Persons exposed to radioactive fallout from the Chernobyl accident as children and adolescents have an increased risk of follicular adenoma or benign tumor of the thyroid gland, according to researchers at Columbia University Mailman School of Public Health.
Scientists solve structure of gene regulator that plays key role in cancer
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans. The culmination of 10 years' work, their research paves the way for the development of new cancer therapies.
Presence of gene mutation helps guide thyroid cancer treatment
A specific gene mutation may be useful in predicting the level of aggression of thyroid cancer and help guide treatment options and follow-up care, according to new study findings.
Role of Thyroid Hormones in Slumber Under Investigation at Rutgers-Camden
While the thyroid has long been linked to metabolism, cutting-edge research underway at Rutgers University-Camden is investigating the possibility that thyroid hormones have an important role in sleep regulation.
Ethanol injection helps manage bone metastasis in thyroid cancer patients
Percutaneous ethanol injection (PEI)-an injection of ethanol (alcohol) through the skin directly into a bone tumor to kill cancer cells-may be a valuable ancillary treatment for thyroid cancer patients whose cancer has spread to the bone. Japanese researchers announced these findings during the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine.
Hepatitis C increases risk of non-Hodgkin lymphoma
Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma (malignancy involving lymphatic tissue) of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma, according to a study in the May 9 issue of JAMA.
Lung cancer rates higher among female nonsmokers than previously
Not all lung cancer is due to a lifetime of smoking cigarettes. Sometimes the diagnosis is a mystery, and the stigma surrounding the disease makes it hard for patients to talk about.
Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers. Tests showed that the drug inhibited key targets in the patients' tumours, and now it is being tested in phase II clinical trials.
More Thyroid Cancer News Articles
 | Breast Cancer and Iodine : How to Prevent and How to Survive Breast Cancer by Dr. David Derry M.D., Ph.D. This book is about cause, prevention and treatment of breast cancer. Breast cancer has two phases. The first one, from abnormal cells up to carcinoma in situ reverses with iodine. The second phase, invasion, is controlled by connective tissue thyroid... |
 | Thyroid Cancer: A Guide for Patients This book is a valuable and extensive source of information about thyroid cancer and is specifically written for the patient with thyroid cancer. However, family and friends of patients who have thyroid cancer will also find this book useful. The book discusses a wide spectrum of aspects about thyroid nodules and cancer. It is discusses the basics of the thyroid gland, the evaluation of... |
 | The Thyroid Cancer Book by M. Sara Rosenthal, Ph.D. Now in its second edition, the only consumer book on thyroid cancer in plain language, also contains a Low Iodine Cookbook. Recommended by Johns Hopkins Thyroid Tumor Center, The Thyroid Foundation of America, The American Foundation for Thyroid Patients, The Thyroid Foundation of Canada, CancerHelpUK, and thyroid cancer patients from both Thyca and... |
 | Thyroid Cancer by Alan Elias M.D. Thyroid cancer is a relatively uncommon cancer although its incidence is increasing particularly among women. Because of the slow pace of spread of differentiated thyroid cancers a one-size fits all approach to the management of patients with this cancer is to be avoided. In this brief outline of the various types of thyroid cancer and their treatment the author has attempted to provide the... |
 | The Purple Butterfly: Diary of a thyroid cancer patient by Susan Hibberd 'The Purple Butterfly' cameos a year in the life of a thyroid cancer patient. Restrained and sparsely written, it gives the reader a deep insight into the mind of someone who is balancing on the edge of hysteria, yet still feels an obligation to `put on a brave face'. A 'must-read' for anyone supporting a friend or relative through a serious illness - this book tells you what he or she never... |
 | Quick FACTS Thyroid Cancer (Quickfacts) by American Cancer Society What people need to know-right from the start-about their Thyroid cancer More than 1.3 million Americans will be diagnosed with various forms of cancer this year. They, their families, and their caregivers will all be seeking information about their specific cancer type. This guide from the experts at the American Cancer Society gives them what they need to know, right from the... |
 | Thyroid Cancer in Clinical Practice by I. Ross McDougall The book covers all aspects of thyroid cancer, including nodules, pathology, thyroid and whole-body scans, ultrasounds, and other nuclear medicine and radiological studies, as well as follow-up testing and prognosis. It tackles the treatment of differentiated thyroid cancer (the commonest variety) and all aspects of the management including surgery, the role and logistics of radioactive iodine... |
 | Package - The Thyroid Cancer Book and The Low Iodine Diet Cookbook by M. Sara Rosenthal, Norene Gilletz Get both books at a one low... |
 | The Genetics of Complex Thyroid Diseases The autoimmune thyroid diseases and familial thyroid cancers are the current target of molecular thyroid genetics. Unlike the situation in monogenic thyroid diseases, for which the molecular genetics has largely been clarified over the past 20 years, a methodological approach to these more complex forms of thyroid disease has not yet been well established. The determination of susceptibility... |
 | Practical Management of Thyroid Cancer: A Multidisciplinary Approach Written by a multidisciplinary team of experts involved in the development of standards and guidelines for its management in the USA, UK, Europe and Asia, the book contains succinct and knowledgeable summaries of the management of thyroid cancer. Every chapter describes a different aspect of care, and provides clear and detailed information about caring for patients with this group of tumors. ... |
| © 2008 BrightSurf.com |